Skip to content
CancerIndex

Comparison engine

Compare cancers

Two to four cancers side by side. Only facts present in the database are shown; every figure carries its source, period and unit. Entities at different hierarchy depths are labelled so counts are not read as equivalent.

Malignant Breast NeoplasmMalignant Prostate Neoplasm

Compare 2 to 4 cancers. The selection is in the URL — copy it to share this comparison.

Facts

Taxonomy

FactMalignant Breast NeoplasmMalignant Prostate Neoplasm
CancerIndex IDCI-CAN-00000227CI-CAN-00005927
Entity typeCancer FamilyCancer
Hierarchy depth36
Top-level registry siteYesYes
Parents
NCIt / OncoTreeC9335C7378
BadgesSolid tumorTop-levelrarity unknownSolid tumorTop-levelrarity unknown

Taxonomy from NCIt / OncoTree (Curated). Badges are rule-derived from stored attributes.

Facts

US registry figures (latest year available per metric)

FactMalignant Breast NeoplasmMalignant Prostate Neoplasm
US annual deaths43,897count2024 · both sexes · all agescdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		34,815count2024 · both sexes · all agescdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed
US annual new cases291,057count2023 · both sexes · all agescdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		266,307count2023 · both sexes · all agescdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed
US age-standardized mortality10.2per 100,0002024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		7.8per 100,0002024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed
US age-standardized incidence71.3per 100,0002023 · both sexes · all ages · 2000 U.S. standard populationcdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		no observation

Observations as published (site definitions on each entity's Statistics tab). No global figures: IARC / GLOBOCAN is under license review and SEER awaits credentials. For entities below the top level the nearest top-level ancestor's registry figures are shown and labelled; they describe the whole site group, not the subtype.

Facts

Counters (entity + descendants)

FactMalignant Breast NeoplasmMalignant Prostate Neoplasm
Active trials2,627clinicaltrialsComputed1,375clinicaltrialsComputed
Recruiting trials1,396clinicaltrialsComputed744clinicaltrialsComputed
Active Phase III trials320clinicaltrialsComputed148clinicaltrialsComputed
Publications, last 5 years133,010pubmedComputed52,116pubmedComputed
Publications, last 12 months27,734pubmedComputed10,892pubmedComputed
Curated evidence items310civicComputed58civicComputed
Genes with evidence278civicComputed146civicComputed
Genomic cohorts32gdcComputed28gdcComputed
Drugs (any / approved)79 / 43civicComputed18 / 24civicComputed

Counts aggregate over descendants across hierarchy types, so a broad family counts more than one of its subtypes; publication counts are query-based per entity. Counters refreshed 2026-09-29.

Facts

Current ranks

FactMalignant Breast NeoplasmMalignant Prostate Neoplasm
Annual deaths#3 of 3143,897 count · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#5 of 3134,815 count · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence
Annual new cases#1 of 32291,057 count · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#2 of 32266,307 count · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence
Age-standardized mortality rate#3 of 2310.2 per 100,000 · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#2 of 2618.3 per 100,000 · USA · Male · all ages · 2024 · top-level cancersHigh confidence
Age-standardized incidence rate#1 of 2471.3 per 100,000 · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#1 of 27121.8 per 100,000 · USA · Male · all ages · 2023 · top-level cancersHigh confidence
Mortality-to-incidence ratio#25 of 310.15 ratio · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#27 of 310.13 ratio · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence
Trial Gap Index#20 of 31-3.4 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#13 of 310 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence
Research Gap Index#22 of 31-6.7 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#20 of 31-6.6 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence
Active clinical trials#2 of 362,627 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#5 of 361,375 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Recruiting clinical trials#2 of 361,396 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#5 of 36744 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Active Phase III trials#2 of 36320 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#5 of 36148 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Publications, last 5 years#1 of 36133,010 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#3 of 3652,116 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Publications, last 12 months#1 of 3627,734 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#3 of 3610,892 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Publication growth#9 of 361.21 ratio · World · both sexes · all ages · latest · top-level cancersMedium confidence#10 of 361.21 ratio · World · both sexes · all ages · latest · top-level cancersMedium confidence
Curated clinical evidence items#3 of 28310 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#11 of 2858 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Genes with curated or cohort evidence#10 of 30278 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#16 of 30146 count · World · both sexes · all ages · latest · top-level cancersMedium confidence
Public genomic cohorts#2 of 2732 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#4 of 2728 count · World · both sexes · all ages · latest · top-level cancersMedium confidence

Ranks come from current snapshots (metric × scope × formula version); "of n" is the number of eligible entities in that scope. Top-level entities are ranked among the 36 mutually exclusive site groups, others among all malignant entities — the two are not comparable. Versioning.

Charts

Side by side

Bars are proportional within each chart; missing values are shown as a dash, never as zero.

US annual deathscount
  1. Malignant Breast Neoplasm43,897
    2024 · observed
  2. Malignant Prostate Neoplasm34,815
    2024 · observed

Registry observation · latest year · Observed

US age-standardized mortalityper 100,000
  1. Malignant Breast Neoplasm10.2
    2024 · observed
  2. Malignant Prostate Neoplasm7.8
    2024 · observed

Per 100,000 · standard population declared by the source

Active trialscount
  1. Malignant Breast Neoplasm2,627
    ClinicalTrials.gov · entity + descendants
  2. Malignant Prostate Neoplasm1,375
    ClinicalTrials.gov · entity + descendants

Counter · Computed

Publications, last 5 yearscount
  1. Malignant Breast Neoplasm133,010
    PubMed · stored query per entity
  2. Malignant Prostate Neoplasm52,116
    PubMed · stored query per entity

Counter · Computed

Comparisons juxtapose facts of different natures (registry counts, registrations, literature volume). They are not a judgment of severity or priority, and population figures never describe an individual.

Data updated 16 hours agoSource updated unknowneach cell states its own period and source